l3012 flg22 medchemexpress hy p1568a l 012 wako (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
93
Structured Review
MedChemExpress
l3012 flg22 medchemexpress hy p1568a l 012 wako
L3012 Flg22 Medchemexpress Hy P1568a L 012 Wako, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1568a/Flagelin+22/pm39855200-657-46-48
Average 93 stars, based on 4 article reviews
L3012 Flg22 Medchemexpress Hy P1568a L 012 Wako, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hy-p1568a/Flagelin+22/pm39855200-657-46-48
Average 93 stars, based on 4 article reviews
l3012 flg22 medchemexpress hy p1568a l 012 wako - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Control:Article Title: Comparative analysis of RNA interference and pattern‐triggered immunity induced by dsRNA reveals different efficiencies in the antiviral response to potato virus X Article Snippet: .. Briefly, individual leaf disks were soaked with 0.1% aniline blue solution (in 50 mM potassium phosphate buffer, pH 8.0) containing either water, 1 μM Article Title: Comparative analysis of RNA interference and pattern-triggered immunity induced by dsRNA reveals different efficiencies in the antiviral response to Potato virus X Article Snippet: .. Briefly, individual leaf disks were soaked with 0,1% aniline blue solution (in 50 mM potassium phosphate buffer, pH 8.0) containing either 1 μM Recombinant:Article Title: A pair of LysM receptors mediates symbiosis and immunity discrimination in Marchantia. Article Snippet: Article Whole Genome Amplification:Article Title: A pair of LysM receptors mediates symbiosis and immunity discrimination in Marchantia. Article Snippet: Article Activation Assay:Article Title: Nanotube topography inhibits NLRP3 inflammasome activation by reducing microtubule glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL Article Title: Nanotube Topography Inhibits NLRP3 Inflammasome Activation by Reducing Microtubule Glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/ mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL Transfection:Article Title: Nanotube topography inhibits NLRP3 inflammasome activation by reducing microtubule glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL Article Title: Nanotube Topography Inhibits NLRP3 Inflammasome Activation by Reducing Microtubule Glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/ mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL Inhibition:Article Title: Nanotube topography inhibits NLRP3 inflammasome activation by reducing microtubule glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL Article Title: Nanotube Topography Inhibits NLRP3 Inflammasome Activation by Reducing Microtubule Glutamylation Article Snippet: .. The concentrations of agonists or stimuli that were used to activate the NLRP3, AIM2, and NLRC4 inflammasomes were as follows: For NLRP3 inflammasome activation, BMDMs were primed with LPS (200 ng/mL) for 4 h, followed by stimulation with 5 mM ATP (HY-B2176, MedChemExpress) for 1 h or 10 μM nigericin (HY-100381, MedChemExpress) for 1 h. For AIM2 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 1 μg/ mL Poly (dA:dT) (tlrl-patn, Invivogen) using Lipofectamine 2000 for 1 h. For NLRC4 inflammasome activation, macrophages were primed with LPS (100 ng/mL) for 4 h, then transfected with 2 μg/mL |
